Title of article :
RisperidoneInduced Erythema Multiforme Minor: A Case Report
Author/Authors :
Negintaji ، Sina Student Research Committee, School of Pharmacy - Shahid Sadoughi University of Medical Sciences , Bidaki ، Reza Department of Psychiatry - Research Center of Addiction and Behavioral Sciences, School of Medicine, Diabetes Research Center - Shahid Sadoughi University of Medical Sciences and Health Services , Zare Kamali ، Javad Student Research Committee, School of Pharmacy - Shahid Sadoughi University of Medical Sciences , Saghafi ، Fatemeh Department of Clinical Pharmacy - School of Pharmacy and Pharmaceutical Sciences Research Center - Shahid Sadoughi University of Medical Sciences , Naseri Bafrouie ، Maryam Department of Psychiatry - School of Medicine - Shahid Sadoughi University of Medical Sciences and Health Services , Tabaei Zadeh ، Nilofar Department of Psychiatry - School of Medicine - Shahid Sadoughi University of Medical Sciences and Health Services , Azadi ، Hossein Department of Psychiatry - School of Medicine - Shahid Sadoughi University of Medical Sciences and Health Services
From page :
28119
To page :
28119
Abstract :
Erythema Multiforme (EM) is a hypersensitivity reaction that can be triggered by an infection or particular medications. Erythema multiforme minor (EM minor) represents localized skin lesions with minimal or no mucosal involvement. Only a few case of EM associated with risperidone are found in the scientific literature. In this case report, the administration of the risperidone resulted in the rapid appearance of skin lesions. Erythematous lesions were recovered upon discontinuation of the drug and no new skin lesion was observed. A 52yearold male patient was admitted to the psychiatry hospital because of developing schizophrenic symptoms. At the time of admission, risperidone was added to her previous drug regimen. Two weeks later, the patient returned with a complaint of progressively increasing rashes over his body. The patient was diagnosed with EM minor. The prescribed risperidone was discontinued due to its sideeffect profile and the patient’s drug regimen was changed entirely to the olanzapine, haloperidol, and topical clobetasol. At one month follow up visit, his skin lesions were satisfactorily controlled.
Keywords :
Erythema multiforme , Skin lesions , Antipsychotic medication , Risperidone
Journal title :
International Journal of Medical Toxicology and Forensic Medicine
Journal title :
International Journal of Medical Toxicology and Forensic Medicine
Record number :
2628974
Link To Document :
بازگشت